SEARLE's CALAN 1990 SALES APPROACH $ 470 MIL. DESPITE COMPETITION IN CALCIUM ANTAGONIST MARKET; DICLOFENAC/MISOPROSTOL COMBO NDA TARGETED FOR 1991

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".